Showing results (331-340 of 360) with videos related to
Sort By:
Pageof 36
Science (New York, N.Y.)|June 21, 2008
Modulation of gene expression via disruption of NF-kappaB signaling by a bacterial small moleculeVladimir V Kravchenko, Gunnar F Kaufmann, John C Mathison, et al.Science (New York, N.Y.)|November 8, 2003
Evidence for ozone formation in human atherosclerotic arteriesPaul Wentworth, Jorge Nieva, Cindy Takeuchi, et al.Molecular Pharmaceutics|December 23, 2014
Flagellin as carrier and adjuvant in cocaine vaccine developmentJonathan W Lockner, Lisa M Eubanks, Jennifer L Choi, et al.Proceedings of the National Academy of Sciences of the United States of America|May 8, 2013
Dynamic vaccine blocks relapse to compulsive intake of heroinJoel E Schlosburg, Leandro F Vendruscolo, Paul T Bremer, et al.Bioorganic & Medicinal Chemistry Letters|December 31, 2010
Synthesis of 'clickable' acylhomoserine lactone quorum sensing probes: unanticipated effects on mammalian cell activationAmanda L Garner, Jing Yu, Anjali Kumari Struss, et al.Human Gene Therapy|November 13, 2012
Disrupted adenovirus-based vaccines against small addictive molecules circumvent anti-adenovirus immunityBishnu P De, Odelya E Pagovich, Martin J Hicks, et al.Proceedings of the National Academy of Sciences of the United States of America|August 13, 2014
Inhibitor of MYC identified in a Kröhnke pyridine libraryJonathan R Hart, Amanda L Garner, Jing Yu, et al.Bioorganic & Medicinal Chemistry|July 25, 2018
Synthetic molecules for disruption of the MYC protein-protein interfaceNicholas T Jacob, Pedro O Miranda, Ryan J Shirey, et al.Science (New York, N.Y.)|November 16, 2002
Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammationPaul Wentworth, Jonathan E McDunn, Anita D Wentworth, et al.Journal of Medicinal Chemistry|September 4, 2020
Catch and Anchor Approach To Combat Both Toxicity and Longevity of Botulinum Toxin ALucy Lin, Margaret E Olson, Takashi Sugane, et al.Pageof 36